Fingolimod After Natalizumab & Short-term Relapse Risk MStranslate March 27, 2014 Fingolimod, Natalizumab, Research, Treatments Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...
Google Hangout – Multiple Sclerosis Q&A MStranslate February 18, 2014 Research, Treatments The first Google Hangout gave members of our community an opportunity to chat with MS researcher and MStranslate co-founder, Brett...
Multiple Sclerosis Treatments Can Decrease Flu Vaccine Effectiveness MStranslate January 20, 2014 Treatments By Brett Drummond Most current treatment options for MS involve altering and often suppressing the immune system. In many instances, this leads to an increased susceptibility to infection. Therefore,...
The Different Stages of Clinical Development MStranslate December 22, 2013 Research, Treatments, Understanding Science Often, we post stories on our social media pages that outline potential new multiple sclerosis therapies in different phases of clinical development. Here, we discuss what happens at each phase in the process...
